Pacific Biosciences of California PACB Service — Contract with customer, liability
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's service — contract with customer, liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's service — contract with customer, liability?
- Pacific Biosciences of California (PACB) reported service — contract with customer, liability of $19.9M in Q1 2026.
- How has Pacific Biosciences of California's service — contract with customer, liability changed year-over-year?
- Pacific Biosciences of California's service — contract with customer, liability decreased by 5.7% year-over-year, from $21.1M to $19.9M.
- What is the long-term trend for Pacific Biosciences of California's service — contract with customer, liability?
- Over 2 years (2021 to 2025), Pacific Biosciences of California's service — contract with customer, liability has grown at a -9.1% compound annual growth rate (CAGR), from $99.2M to $82M.
- What does service — contract with customer, liability mean?
- This represents the total financial obligation arising from service agreements where the company has received consideration but has not yet satisfied the performance obligations. It reflects the balance of unearned service revenue that must be fulfilled through future maintenance, support, or technical assistance. Monitoring this liability helps assess the company's future service delivery commitments and potential for future revenue recognition.